Original paper

When can active surveillance be less active? Prediction of long-term nonreclassification for men with low-risk prostate cancer.

Volume: 36, Issue: 6_suppl, Pages: 140 - 140
Published: Feb 20, 2018
Abstract
140 Background: Active surveillance is endorsed as the preferred management strategy for most men with low-risk prostate cancer. However, nearly all active surveillance protocols entail prostate specific antigen (PSA) testing every 3-6 months, and prostate biopsies every 1-2 years. For many men with indolent tumors, this regimen is overly intense, and exposes men to the discomfort, risks, and costs of repeated biopsies. We aimed to determine if...
Paper Details
Title
When can active surveillance be less active? Prediction of long-term nonreclassification for men with low-risk prostate cancer.
Published Date
Feb 20, 2018
Volume
36
Issue
6_suppl
Pages
140 - 140
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.